Tricuspid Valve Regurgitation clinical trials at UCSF
1 research study open to eligible people
Showing trials for
TRISCEND II Pivotal Trial
open to eligible people ages 18 years and up
Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system
San Francisco, California and other locations
Our lead scientists for Tricuspid Valve Regurgitation research studies include Sammy Elmariah, MD.